Differences in the characteristics of patients with non-valvular atrial fibrillation who are newly prescribed apixaban, rivaroxaban, dabigatran and VKA in general practice in the UK
Event:
ESC Congress 2016
Topic:
Atrial fibrillation (AF)
Session:
Anticoagulation in atrial fibrillation
